Clinical Trial Update: Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation study of desmoteplase in acute ischemic stroke (DEDAS) completed, evaluating escalating doses of the thrombolytic. The sponsor is PAIO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Desmoteplase (Desmoteplase)

Snippet

Sponsor: PAION Deutschland GmbH | Conditions: Stroke | Phase 1, Phase 2 | Status: COMPLETED